drugset / Trial / NCT04282200
Ketorolac in Acute Pancreatitis
RandomizedParallel-groupOpen-labelSupportive care
Summary
This study will compare pain management strategies for patients hospitalized with acute pancreatitis. Standard of care pain management will be compared to standard of care plus intravenous ketorolac.
Timeline
- Start
- 2020-02-24
- Primary completion
- 2021-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 30 mg | Intravenous |